Related Experiment Video
Updated: Jun 22, 2026

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus
Published on: October 7, 2011
Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin
S K Dhar1, K Yoshida, Y Machida
1Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Abstract:
A hypomorphic mutation made in the ORC2 gene of a human cancer cell line through homologous recombination decreased Orc2 protein levels by 90%. The G1 phase of the cell cycle was prolonged, but there was no effect on the utilization of either the c-Myc or beta-globin cellular origins of replication. Cells carrying this mutation failed to support the replication of a plasmid bearing the oriP replicator of Epstein Barr virus (EBV), and this defect was rescued by reintroduction of Orc2. Orc2 specifically associates with oriP in cells, most likely through its interaction with EBNA1. Geminin, an inhibitor of the mammalian replication initiation complex, inhibits replication from oriP. Therefore, ORC and the human replication initiation apparatus is required for replication from a viral origin of replication.
Insights
A mutation in the ORC2 gene reduced Orc2 protein, prolonging cell cycle but not affecting cellular DNA replication origins. Viral replication from Epstein-Barr virus origins (oriP) was impaired, showing ORC
Area of Science:
- Molecular Biology
- Cell Biology
- Virology
Background:
- The Origin Recognition Complex (ORC) is crucial for DNA replication initiation in eukaryotes.
- Understanding ORC's role in viral DNA replication is essential for comprehending viral lifecycles and developing antiviral strategies.
Purpose of the Study:
- To investigate the role of the ORC2 gene and its protein product in DNA replication, specifically examining its necessity for viral DNA replication from Epstein-Barr virus (EBV) origins.
- To determine if the human replication initiation apparatus is involved in the replication of viral origins.
Main Methods:
- Homologous recombination was used to create a hypomorphic mutation in the ORC2 gene in a human cancer cell line, reducing Orc2 protein levels.
- Cell cycle progression was analyzed, and the utilization of cellular origins of replication (c-Myc, beta-globin) was assessed.
- Plasmid replication assays using a construct with the EBV oriP replicator were performed in wild-type and mutant cells.
- The effect of reintroducing Orc2 protein and the impact of geminin, a replication inhibitor, on oriP replication were evaluated.
Main Results:
- A hypomorphic mutation in ORC2 significantly decreased Orc2 protein levels (by 90%) and prolonged the G1 phase of the cell cycle.
- The mutation did not affect the utilization of cellular origins of replication like c-Myc or beta-globin.
- Cells with reduced Orc2 failed to replicate plasmids containing the EBV oriP, a defect rescued by Orc2 reintroduction.
- Orc2 was found to associate with oriP, likely via EBNA1, and geminin inhibited oriP replication.
Conclusions:
- The ORC2 gene product (Orc2) is essential for the replication of the Epstein-Barr virus origin (oriP).
- The human replication initiation machinery, including ORC, is required for the replication of this viral origin.
- Orc2's interaction with EBNA1 is likely critical for its role in oriP replication.
Related Concept Videos
Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Viruses of Archaea
Viruses with RNA Genomes
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly

